Imperial College London, a science-based institution based in the centre of the capital, is regarded as one of the UK’s leading institutions. The college has around 15,000 students and 8,000 staff, with a focus on science, engineering, medicine, and business.
The computational medicine research group focuses on developing computational/AI methods that can make a difference in data-driven global health and disease. It has developed of a series of field-changing data analytics frameworks to augment emerging molecular (“-omics”) profiling technologies into clinical decision support, and population health management. The group expertise combines the use of a diverse range of computational techniques from signal processing, imaging informatics, network-based machine learning, natural language processing and high-performance mobile computing for information extraction from heterogeneous biomedical datasets.
The group collaborates with the Vodafone Foundation on the DreamLab-DRUGS and CORONA-AI projects—one of the biggest citizen science projects with over 250,000 engaged users. The projects harness the idle processing power of tens of thousands of smartphones, network-based AI and large-omics data to hunt for drug-food combinations against cancer genomes.
The group focuses on omics-driven precision medicine/nutrition, AI drug repositioning, and digital pathology. The group’s head, Dr Veselkov, has received a World Economic Forum (WEF) Young Scientist Award and served on the WEF Global Agenda Council on the Future of Computing. His research was featured by technology programs BBC Click, Sky Swipe, and numerous media outlets.